Rogaratinib in patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression and effects of mutations in the FGFR signaling pathway.
暂无分享，去创建一个
S. Park | A. Navarro | M. Schuler | H. Richly | M. Joerger | S. Bender | R. Cathomas | M. Schostak | N. Penel | E. Grande | M. Wermke | P. Cassier | L. Nogova | C. Grüllich | P. Ellinghaus | H. Nogai | D. Tai | A. Janitzky | C. Sayehli | Andreas Janitzky | David Wai-Meng Tai | Se Hoon Park | Martin H. Schuler